SAMIK PHARM. CO.,LTD.
014950
企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年6月
SAMIK PHARM. CO.,LTD. mainly engages in prescription drugs among finished pharmaceuticals, with synthetic pharmaceuticals as its main business by production material classification, while also operating a CMO business in parallel. The company develops and produces prescription drugs across various therapeutic areas, centering on treatments for the three major chronic diseases of hypertension, diabetes, and hyperlipidemia, as well as over-the-counter drugs such as motion sickness medicine, tonics for children with weak constitutions, and cold medicines, and conducts research on natural-product-derived new drugs, exploration of low-molecular new drug candidates, improved new drugs, and first-generic development.
代表理事
Lee Chunghwan
成立日期
1980年7月23日
法人类型
韩国创业板
行业分类
Manufacture of synthetic drug and other finished medicaments
法人注册号
12011-0009755
营业执照号
122-81-13217
电话号码
02-928-0661
传真号码
02-927-7525
公司地址
13 Cheongan-ro, Bupyeong-gu, Incheon
评论